M. Roussel

发表

RhD variants in Caucasians: consequences for checking clinically relevant alleles

F. Noizat‐Pirenne, P. Pennec, H. Ansart‐Pirenne, 2004, Transfusion.

Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.

F. Noizat‐Pirenne, Ketty Lee, P. Pennec, 2002, Blood.

Two new alleles of the RHCE gene in Black individuals: the RHce allele ceMO and the RHcE allele cEMI

F. Noizat‐Pirenne, G. Juszczak, P. Rouger, 2001, British journal of haematology.

Molecular background of D(C)(e) haplotypes within the white population

F. Noizat‐Pirenne, A. Rouzaud, G. Juszczak, 2002, Transfusion.

Anti‐HrB and anti‐hrB revisited

G. Juszczak, P. Rouger, B. Pham, 2009, Transfusion.

Analysis of RhCE variants among 806 individuals in France: considerations for transfusion safety, with emphasis on patients with sickle cell disease

G. Juszczak, P. Rouger, B. Pham, 2011, Transfusion.

DAL: a new partial RHD phenotype

F. Noizat‐Pirenne, J. Cartron, H. Ansart‐Pirenne, 2001, Transfusion.

RHD*DOL1 and RHD*DOL2 encode a partial D antigen and are in cis with the rare RHCE*ceBI allele in people of African descent

Michèle Roussel, G. Juszczak, C. Menanteau, 2013, Transfusion.

Molecular analysis of patients with weak D and serologic analysis of those with anti-D (excluding type 1 and type 2)

B. Pham, D. Gien, P. Le Pennec, 2013, Immunohematology.

Anti‐D investigations in individuals expressing weak D Type 1 or weak D Type 2: allo‐ or autoantibodies?

P. Pennec, P. Rouger, B. Pham, 2011, Transfusion.

Anti‐D investigations in individuals expressing weak D Type 1 or weak D Type 2: allo‐ or autoantibodies?

P. Rouger, B. Pham, T. Peyrard, 2011, Transfusion.